Robert G. Koblin
Corporate Officer/Principal chez Robertson Diagnostic Center
Profil
Robert G.
Koblin has been a Director of Signalife, Inc. since July 11, 2008.
He has been Staff Physician and Instructor at the Cedars-Sinai Medical Center in Los Angeles since 1966, Managing Director of the Robertson Diagnostic Center in Beverly Hills, California since April 2002 and an Assistant Clinical Professor of Medicine at the University of California in Los Angeles since 1982.
Dr. Koblin has more than 30 years of medical experience.
Previously, he was a Director of Signalife from February 2003 to March 2005.
Dr. Koblin received an undergraduate degree from New York University and a Medical degree from Stanford University.
Postes actifs de Robert G. Koblin
Sociétés | Poste | Début |
---|---|---|
Robertson Diagnostic Center | Corporate Officer/Principal | 01/04/2002 |
University of California, Los Angeles | Corporate Officer/Principal | 01/01/1982 |
Anciens postes connus de Robert G. Koblin
Sociétés | Poste | Fin |
---|---|---|
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | Directeur/Membre du Conseil | 10/06/2009 |
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | Directeur/Membre du Conseil | 01/03/2005 |
Formation de Robert G. Koblin
Stanford University | Doctorate Degree |
New York University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Signalife, Inc.
Signalife, Inc. Medical SpecialtiesHealth Technology The Group's principal activity is to develop, research and market heart monitors and other diagnostic medical devices. The Group's product Model 100 ambulatory monitor system which monitor, which collects, processes and records data, as well as will enable physicians to monitor the changes in the patient's physiological signals and assist in the detection of heart disease through the conduct of electrocardiogram tests. The Group is a development stage company. | Health Technology |
Robertson Diagnostic Center |